Literature DB >> 29187428

Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma - A Comprehensive Review.

Tomasz Berus1, Agnieszka Halon2, Anna Markiewicz3, Jolanta Orlowska-Heitzman4, Bozena Romanowska-Dixon3, Piotr Donizy2.   

Abstract

Uveal melanoma is the most prevalent primary intraocular cancer in adults. Although it accounts for only 5% of all melanomas, it is responsible for 13% of deaths due to this type of cancer. A wide variety of therapeutic options of primary tumor is available and progress in its management is noticeable. The fact still remains, however, that almost half of patients develop metastases which may be due to practically undetectable cancer spread present as early as at diagnosis of the primary focus. Metastatic disease is uniformly fatal despite systemic therapy. Prediction of metastasis is crucial for prognosis. It also allows targeting of emerging new therapeutic methods to the appropriate group of patients. The Authors reviewed literature concerning epidemiology and etiopathogenesis of uveal melanoma, and its clinical, histopathological and cytogenetic prognosticators. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Uveal melanoma; malignant melanoma; metastases; prognosis; prognostic factors; review

Mesh:

Year:  2017        PMID: 29187428     DOI: 10.21873/anticanres.12110

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Emerging roles of microRNAs and their implications in uveal melanoma.

Authors:  Chun Yang; Yuejiao Wang; Pierre Hardy
Journal:  Cell Mol Life Sci       Date:  2020-08-11       Impact factor: 9.261

2.  Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases.

Authors:  Zenan Lin; Daniela Süsskind
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-04       Impact factor: 4.553

Review 3.  Imaging of Uveal Melanoma-Current Standard and Methods in Development.

Authors:  Małgorzata Solnik; Natalia Paduszyńska; Anna M Czarnecka; Kamil J Synoradzki; Yacoub A Yousef; Tomasz Chorągiewicz; Robert Rejdak; Mario Damiano Toro; Sandrine Zweifel; Katarzyna Dyndor; Michał Fiedorowicz
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

4.  Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.

Authors:  Mehdi Mazloumi; Pornpattana Vichitvejpaisal; Lauren A Dalvin; Antonio Yaghy; Kathryn G Ewens; Arupa Ganguly; Carol L Shields
Journal:  JAMA Ophthalmol       Date:  2020-03-01       Impact factor: 7.389

5.  Mutational Landscape of the BAP1 Locus Reveals an Intrinsic Control to Regulate the miRNA Network and the Binding of Protein Complexes in Uveal Melanoma.

Authors:  Amit Sharma; Arijit Biswas; Hongde Liu; Sagnik Sen; Anoosha Paruchuri; Panagiotis Katsonis; Olivier Lichtarge; Tikam Chand Dakal; Ujjwal Maulik; M Michael Gromiha; Sanghamitra Bandyopadhyay; Michael Ludwig; Frank G Holz; Karin U Loeffler; Martina C Herwig-Carl
Journal:  Cancers (Basel)       Date:  2019-10-19       Impact factor: 6.639

Review 6.  Role of Natural Killer Cells in Uveal Melanoma.

Authors:  Asad Javed; Mohammed Milhem
Journal:  Cancers (Basel)       Date:  2020-12-09       Impact factor: 6.639

7.  MR imaging characteristics of uveal melanoma with histopathological validation.

Authors:  Teresa A Ferreira; Myriam G Jaarsma-Coes; Marina Marinkovic; Berit Verbist; Robert M Verdijk; Martine J Jager; Gregorius P M Luyten; Jan-Willem M Beenakker
Journal:  Neuroradiology       Date:  2021-10-31       Impact factor: 2.804

8.  Is Collaborative Ocular Melanoma Study (COMS) still relevant?

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

9.  Analysis of local recurrence causes in uveal melanoma patients treated with 125I brachytherapy - a single institution study.

Authors:  Joanna Kowal; Anna Markiewicz; Magdalena Dębicka-Kumela; Anna Bogdali; Barbara Jakubowska; Izabella Karska-Basta; Bożena Romanowska-Dixon
Journal:  J Contemp Brachytherapy       Date:  2019-12-16

Review 10.  Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets.

Authors:  Maria Sofia Basile; Emanuela Mazzon; Paolo Fagone; Antonio Longo; Andrea Russo; Matteo Fallico; Vincenza Bonfiglio; Ferdinando Nicoletti; Teresio Avitabile; Michele Reibaldi
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.